Adriana E Tron

5PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Dec 29, 2025
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Jinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis

|Jul 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML.

Pau Montesinos, Dylan M Marchione, Christian Recher

|Jul 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula

|Jun 24, 2023
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.

Courtney D DiNardo, Stéphane De Botton, Daniel A Pollyea

Pageof 1

Frequent Collaborators

2 joint publications

Courtney D DiNardo

2 joint publications

Stéphane De Botton

2 joint publications

Robert T Manguso

2 joint publications

Daniel P Cahill